|
|
||||||||
Published online before print August 26, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

* Department of Internal Medicine, University Hospital Groningen, The Netherlands; and
Xeptagen, SpA, Pozzuoli, Italy
1 Correspondence: Department of Internal Medicine, University Hospital Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. E-mail: c.g.m.kallenberg{at}int.azg.nl
Antineutrophil cytoplasm autoantibodies with specificity for proteinase 3 (PR3) are thought to play a major role in the pathogenesis of Wegeners granulomatosis (WG), presumably by their potential to activate neutrophils. In patients with WG, high expression of PR3 on the surface of nonprimed neutrophils is associated with an increased incidence and rate of relapse. In this study, we analyzed the functional significance of constitutive PR3 expression for neutrophil activation as induced by anti-PR3 antibody. Therefore, primed and nonprimed neutrophils were stimulated with the monoclonal anti-PR3 antibody PR3G-3. Activation was measured as actin polymerization by the phalloidin assay as an early, detectable activation event and oxidative burst by the dihydrorhodamine assay, as a late, detectable activation event. In contrast to the oxidative burst, we found that anti-PR3 antibody-induced actin polymerization could be triggered in neutrophils without priming with tumor necrosis factor
(TNF-
). In addition, a correlation was found between the level of PR3 expression on the surface of these nonprimed neutrophils and the degree of actin polymerization. However, after priming with TNF-
, no correlation was found between membrane expression of PR3 and the level of actin polymerization or respiratory burst as induced by anti-PR3 antibody. These data suggest that the presence of PR3 on the surface of nonprimed neutrophils has consequences for their susceptibility to the initial activation step by anti-PR3 antibodies. These data may be relevant in view of the observed relation between membrane expression of PR3 on nonprimed neutrophils of patients with WG and their susceptibility for relapses.
Key Words: ANCA WG PMN vasculitis
This article has been cited by other articles:
![]() |
T. Matsumoto, T. Kaneko, M. Seto, H. Wada, T. Kobayashi, K. Nakatani, H. Tonomura, Y. Tono, M. Ohyabu, T. Nobori, et al. The Membrane Proteinase 3 Expression on Neutrophils Was Downregulated After Treatment With Infliximab in Patients With Rheumatoid Arthritis Clinical and Applied Thrombosis/Hemostasis, April 1, 2008; 14(2): 186 - 192. [Abstract] [PDF] |
||||
![]() |
R. A.F. de Lind van Wijngaarden, L. van Rijn, E. C. Hagen, R. A. Watts, G. Gregorini, J. W. C. Tervaert, A. D. Mahr, J. L. Niles, E. de Heer, J. A. Bruijn, et al. Hypotheses on the Etiology of Antineutrophil Cytoplasmic Autoantibody Associated Vasculitis: The Cause Is Hidden, but the Result Is Known Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 237 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P van Rossum, M. G Huitema, C. A Stegeman, M. Bijl, K. de Leeuw, M. A Van Leeuwen, P. C Limburg, and C. G M Kallenberg Standardised assessment of membrane proteinase 3 expression. Analysis in ANCA-associated vasculitis and controls Ann Rheum Dis, October 1, 2007; 66(10): 1350 - 1355. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Watts, L. Harper, D. Jayne, J. Levy, C. Pusey, C. Savage, D. G. I. Scott, and J. Williams Translational research in autoimmunity: aims of therapy in vasculitis Rheumatology, May 1, 2005; 44(5): 573 - 576. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |